Equate Dual Action Complete and Zyprexa Intramuscular
Determining the interaction of Equate Dual Action Complete and Zyprexa Intramuscular and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using OLANZapine together with famotidine can increase the risk of an irregular heart rhythm that may be serious and potentially life-threatening, although it is a relatively rare side effect. You may be more susceptible if you have a heart condition called congenital long QT syndrome, other cardiac diseases, conduction abnormalities, or electrolyte disturbances (for example, magnesium or potassium loss due to severe or prolonged diarrhea or vomiting). Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations during treatment with these medications, whether together or alone. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: It is uncertain whether olanzapine causes clinically significant prolongation of the QT interval. In pooled studies of adults as well as pooled studies of adolescents, there were no significant differences between olanzapine and placebo in the proportion of patients experiencing potentially important changes in ECG parameters, including QT, QTcF (Fridericia-corrected), and PR intervals. In clinical trials, clinically meaningful QTc prolongations (QTcF >=500 msec at any time post-baseline in patients with baseline QTcF
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Zyprexa (olanzapine)." Lilly, Eli and Company, Indianapolis, IN.
Generic Name: calcium carbonate / famotidine / magnesium hydroxide
Brand name: Dual Action Complete, Duo Fusion, Pepcid Complete
Synonyms: Dual Action Complete
Generic Name: olanzapine
Brand name: Zyprexa Intramuscular, Zyprexa, Zyprexa Zydis, Zyprexa Relprevv
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Equate Dual Action Complete-Zyprexa Relprevv
- Equate Dual Action Complete-Zyprexa Zydis
- Equate Dual Action Complete-Zyrtec
- Equate Dual Action Complete-Zyrtec (Cetirizine Capsules and Tablets)
- Equate Dual Action Complete-Zyrtec (Cetirizine Chewable Tablets)
- Equate Dual Action Complete-Zyrtec (Cetirizine Orally Disintegrating Tablets)
- Zyprexa Intramuscular-Equate Mini Nicotine Lozenge - Fast Dissolving - Mint
- Zyprexa Intramuscular-Equate Nicotine Lozenge
- Zyprexa Intramuscular-Equate Sleep Aid
- Zyprexa Intramuscular-Equetro
- Zyprexa Intramuscular-Equilizer Gas Relief
- Zyprexa Intramuscular-Equipto-Amitriptyline Cream